Gene Therapy for Age-related Macular Degeneration Market Size 2020 By Top Key Players, By Type and Application, Forecast to 2025

(MENAFN- BrandEssence market Research Company)

Latest research report on Gene Therapy for Age-related Macular Degeneration Market delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrates its growth trends and competitive landscape as well as the key players in the business.

Get Sample Copy of This Premium Report https://industrystatsreport.com/Request/Sample?ResearchPostId=11998 & RequestType=Sample

Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is directly related to the advancement of age. But smoking also plays a vital role in causing AMD. AMD is characterized by the presence of a blurred area near the center of vision that leads to distorted vision. There are two different types of AMD, including dry (atrophic) AMD (dAMD) and wet (neovascular/exudative) AMD (wAMD). The dAMD is the most common type of AMD and accounts for almost 80%-90% of the overall AMD cases.
 
 It has been observed that age-related macular degeneration (AMD) is one of the major causes for vision loss and is characterized by the formation of a blurred area near the center of vision, a condition that mostly affects the geriatric population. According to the CDC, almost 2 million individuals in the US suffer from AMD and by 2050, this number will reach more than 5 million. This will subsequently demand the need for the development of innovative treatments for AMD, driving the market's growth.
 
 The market research analysts have predicted that with the introduction of techniques such as fluorescein angiography, the global age-related macular degeneration market will register a CAGR of more than 7% by 2020. With the unavailability of FDA-approved treatment for dry AMD (dAMD) and the treatment of wet AMD (wAMD) involving the need of intravitreal injections for an indefinite period, gene therapy is emerging as the most-efficient approach for the treatment of age-related macular degeneration (AMD).
 
 According to this pipeline analysis report, most of the gene therapy molecules in the pipeline are being developed for wet AMD (wAMD). Our market research analysts have also identified that most of these molecules are in the pre-clinical development stage and a considerable number of molecules have been discontinued from development.
 
This report focuses on the global Gene Therapy for Age-related Macular Degeneration status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy for Age-related Macular Degeneration development in United States, Europe and China.
 
  The key players covered in this study
     RetroSense Therapeutics
     REGENXBIO
    AGTC
 
Market segment by Type, the product can be split into
     Subretinal
     Intravitreal
     Unspecified
  Market segment by Application, split into
     Monotherapy
     Combination Therapy

In this study, the years considered to estimate the market size of Gene Therapy for Age-related Macular Degeneration are as follows:
     History Year: 2014-2018
     Base Year: 2018
     Estimated Year: 2019
     Forecast Year 2019 to 2025
 
  Market segment by Regions/Countries, this report covers
     United States
     Europe
     China
     Japan
     Southeast Asia
     India
     Central & South America
 
  The study objectives of this report are:
     To analyze global Gene Therapy for Age-related Macular Degeneration status, future forecast, growth opportunity, key market and key players.
     To present the Gene Therapy for Age-related Macular Degeneration development in United States, Europe and China.
     To strategically profile the key players and comprehensively analyze their development plan and strategies.
     To define, describe and forecast the market by product type, market and key regions.
 
 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get Full Report: https://industrystatsreport.com/Lifesciences-and-Healthcare/Dynamic-Growth-On-Gene-Therapy-for-Age-related-Macular-Degeneration-Market-Size-and-Share/Summary                                             

About us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us  at: +44-2038074155 or mail us at 

Interested in this report?

MENAFN02072020007010696ID1100423982